Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

These 3 Stocks Are a Must When Building Your Dividend Portfolio

Since the uncertain economic conditions are expected to keep the stock market under pressure, dividend-paying stocks Pfizer (PFE), ICL Group (ICL), and ARC Document Solutions (ARC) could be solid additions to your portfolio for generating a steady income stream. Keep reading….

StockNews.com

3 Stocks That Are Great for Passive Income Investors

Though the U.S. economy bounced back after shrinking in the first half of the year, falling consumer spending and the rate hikes to tame high inflation might lead the economy into a recession. Hence, investors looking for passive income could invest in fundamentally sound dividend-paying stocks Pfizer (PFE), Sanofi (SNY),…

StockNews.com

Tesla's Autopilot Draws Regulatory Scrutiny, Volkswagen Expects Supply Crisis To Continue, TikTok To Launch Standalone Gaming Channel: Top Stories Friday, Oct. 28

Wall Street Journal Tesla’s Autopilot Draws Regulatory Ire From DoJ and SEC

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Shanghai district orders mass COVID-19 testing, lockdown

China's largest city of Shanghai is ordering mass testing on all 1.3 million residents of its downtown Yangpu district and confining them to their homes at least until results are known

The Independent UK

Elon Musk & Philippine Billionaire Come Together For Satellite Internet Service In Southeast Asia, Disney May Track Your Theme Park Preferences, Struggling Credit Suisse Reveals Business Overhaul: Top Stories Thursday, Oct. 27

Benzinga

'Media literacy' advocates push to create savvier consumers of news and information

The Instagram headline was pithy and alarming: “Head of Pfizer Research: Covid Vaccine is Female Sterilization.” And the report, from a murky source, could have had real-world consequences, coming in 2020, just as the U.S. rolled out the first vaccines to combat the coronavirus pandemic.

Los Angeles Times

Lisa Jarvis: What parents can do as RSV spikes among children

A surge in cases of a common respiratory virus is filling up pediatric hospital beds around the U.S. The early and swift arrival of respiratory syncytial virus, or RSV, is stretching the limits of an already exhausted health care system. Layer on COVID and the flu, and you’ve got the…

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Study confirms AstraZeneca jab's higher risk of very rare clot

Paris (AFP) - AstraZeneca's Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday.

AFP

What Are Whales Doing With Pfizer

Someone with a lot of money to spend has taken a bullish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Myovant Sciences Accepts Slightly Higher Takeover Offer

The drug developer finally agreed to a takeover offer from its majority shareholder after rejecting advances earlier this month.

The Street

Bill Gates' Big Vaccine Bet Might Beat Pfizer

A vaccine candidate from Vaxcyte appears to offer better protection against bacterial infections than the Prevnar franchise from Pfizer.

The Street

Only a quarter of Irish children got Covid-19 vaccine as HSE gives away 300k doses

Poor uptake in this age group is now likely to significantly add to the stress expected in the health sector over the coming winter months as services struggle to cope with a ‘twindemic’ of flu and Covid

Irish Mirror

Check Out What Whales Are Doing With PFE

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 20 strange trades.

Benzinga

Pfizer Could Be Raising the Price of Its Covid Vaccines Soon

There are reports that falling demand will necessitate an increase in prices for the company's two breakthrough covid-19 vaccines.

The Street

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Anger as Pfizer reveals Covid shots will cost up to $130 when US government pulls free programme

Pfizer insists most Americans will still be able to access free vaccines, but public health advocates accuse it of “shameless” profiteering

StockNews.com

3 Recession-Proof Stocks to Buy in October

Various headwinds, including the widespread fears of a recession, have kept the market clenched in a bear grip. Amid this backdrop, resilient stocks Pfizer (PFE), Waste Management (WM), and Ingles Markets (IMKTA), which belong to essential sectors and possess inelastic demand for their products or services, could be appropriate additions…

The Independent UK

Pfizer says COVID-19 vaccine will cost $110-$130 per dose

Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots

Axios

Pfizer will start charging $110-$130 a dose for COVID vaccines next year

Price increases, while expected, could lead to higher insurance premiums.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Pfizer Quadruples Its Covid Shot Price — And Other Vaccine Stocks Rocket

Moderna snagged an upgrade Friday on views it will hike charges for its Covid vaccine, as Pfizer plans to charge up to $130 for its shot.

ABC News

Did Pfizer make a 'scandalous' admission to the European Parliament about its COVID-19 vaccine?

Despite a claim that has gone viral, Pfizer never said that pre-market trials of its COVID-19 vaccine tested for its effect on transmission of the virus.

StockNews.com

4 Income Stocks You Could Buy and Hold Forever

As the central banks worldwide are determined to battle sky-high inflation with big rate hikes, top economists warn of a global recession on the way. While volatility is rife in the stock market, reliable dividend-paying stocks Pfizer (PFE), McKesson (MCK), Nutrien (NTR), and Genie Energy (GNE) might be ideal investments…

Newsroom.co.nz

At-risk populations in the dark about Covid treatments

Years of sometimes confusing messaging on Covid has left half the people eligible for antiviral treatment unaware of it

The Independent UK

US clears Novavax COVID booster dose

The Food and Drug Administration has authorized a booster dose of the COVID-19 vaccine made by Novavax

Chronicle Live

Covid winter boosters, new vaccines and why side effects may be different

Everybody over 50 is invited for a winter coronavirus jab but not everybody will get the new dual/bivalent vaccines that target multiple strains

Chicago Sun-Times

Ask the Doctors: Omicron variant COVID-19 boosters are now recommended for all

More than 90% of new COVID9 cases nationwide are being caused by infection with the omicron variant. So it’s a relief that there’s a tool to fight that.

1 … 29 30 31 32

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.